Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-22-000051
Filing Date
2022-05-12
Accepted
2022-05-12 16:04:01
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20220331.htm   iXBRL 10-Q 840385
2 EX-10.1 ex101_10q033122.htm EX-10.1 552540
3 EX-10.2 ex102_10q033122.htm EX-10.2 126128
4 EX-10.3 ex_102noneedirectorcomppol.htm EX-10.3 34405
5 EX-31.1 exhibit311_20220331.htm EX-31.1 15476
6 EX-31.2 exhibit312_20220331.htm EX-31.2 15232
7 EX-32.1 exhibit321_20220331.htm EX-32.1 4343
8 EX-32.2 exhibit322_20220331.htm EX-32.2 4331
14 dare-20220331_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-22-000051.txt   5671841

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20220331.xsd EX-101.SCH 43430
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20220331_cal.xml EX-101.CAL 36908
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20220331_def.xml EX-101.DEF 189528
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20220331_lab.xml EX-101.LAB 488150
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20220331_pre.xml EX-101.PRE 297210
53 EXTRACTED XBRL INSTANCE DOCUMENT dare-20220331_htm.xml XML 556206
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 22917699
SIC: 2834 Pharmaceutical Preparations